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ABSTRACT
Membraneless organelles (MOs) are dynamic liquid
condensates that host a variety of specific cellular
processes, such as ribosome biogenesis or RNA
degradation. MOs form through liquid–liquid phase
separation (LLPS), a process that relies on multiva-
lent weak interactions of the constituent proteins and
other macromolecules. Since the first discoveries of
certain proteins being able to drive LLPS, it emerged
as a general mechanism for the effective organiza-
tion of cellular space that is exploited in all kingdoms
of life. While numerous experimental studies report
novel cases, the computational identification of LLPS
drivers is lagging behind, and many open questions
remain about the sequence determinants, composi-
tion, regulation and biological relevance of the re-
sulting condensates. Our limited ability to overcome
these issues is largely due to the lack of a dedicated
LLPS database. Therefore, here we introduce PhaSe-
Pro (https://phasepro.elte.hu), an openly accessible,
comprehensive, manually curated database of exper-
imentally validated LLPS driver proteins/protein re-
gions. It not only provides a wealth of information on
such systems, but improves the standardization of
data by introducing novel LLPS-specific controlled
vocabularies. PhaSePro can be accessed through an
appealing, user-friendly interface and thus has defi-
nite potential to become the central resource in this
dynamically developing field.
INTRODUCTION
One of the most exciting recent developments in the field
of molecular cell biology is the discovery that certain pro-
teins can undergo liquid–liquid phase separation (LLPS) in-
side the cell, driving the formation of diverse membrane-
less organelles/biological condensates, such as stress gran-
ules, P-bodies, the nucleolus and postsynaptic densities (1–
3). These dynamic, non-stoichiometric supramolecular as-
semblies represent a unique functional and structural level
of cellular organization. Their functions often cannot be de-
rived from the functions of individual proteins, but emerge
from the collective behaviour of their constituent macro-
molecules (4). They confer a wide range of functional ad-
vantages on cells (5) due to their unique material properties
(5,6), and rapid responses to environmental triggers (8). It
was also proposed that multiple non-specific weak interac-
tions can more readily emerge and be maintained through
evolution than specific strong interactions, and thus liq-
uid condensates exhibit a favourable cost-benefit ratio (7).
Ever since the discovery and first analysis of liquid droplets
in Drosophila embryos (9), an increasing number of cel-
lular functions have been ascribed to such liquid conden-
sates, including the regulation of most stages of the life cycle
of RNAs (10–13), transcriptional regulation and silencing
(14,15) and the signal transduction networks of membrane
receptors (16,17). LLPS has emerged as a general mecha-
nism of cellular organization, exploited not only by eukary-
otic cells, but also by bacteria and viruses (18,19). Besides
diverse physiological roles of these dense liquid condensates
(1–3), their fundamental roles are also highlighted by the
fact that mutations affecting their regulation are often im-
plicated in devastating neurological disorders, such as amy-
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otrophic lateral sclerosis (ALS) and frontotemporal demen-
tia (FTD), and are also associated with cancers and muscu-
lar atrophies (20).
The ability to drive liquid–liquid phase separation
(LLPS) is encoded in protein sequences, but it can be
achieved by diverse functional modules, including dis-
ordered regions of low sequence complexity, multiva-
lent domain – motif interactions, RNA binding domains,
oligomerization domains and various combinations of
these modules (21). As a unifying feature, LLPS is typi-
cally driven by multivalent weak interactions, which ensure
the dynamic, liquid-like properties of the resulting conden-
sates. Liquid condensates show a broad range of morpholo-
gies, shapes, sizes and compositions (2). Some of them are
constituted of a single dense phase, while others show in-
tricate core-shell structures, in which multiple immiscible
phases are embedded into each other as dictated by their
surface tension and viscosity properties (13,22,23). Many
have a rounded shape as true liquid droplets (24,25), or
form more irregular structures along the surface of mem-
branes (16,17,26). While some only contain a few types of
macromolecules (27,28), others, such as P-bodies and stress
granules, host hundreds of proteins and thousands of RNA
molecules (29–32). It has been proposed that regardless of
the size and compositional richness of the condensates, usu-
ally only one or a few proteins, referred to as ‘scaffolds’,
drive their formation. The other constituents, the so-called
‘client’ proteins, do not substantially contribute to the for-
mation of the condensates. Through interactions with the
scaffold, clients are readily compartmentalized by the con-
densate and often directly promote its characteristic func-
tions (33,34).
While in the last years an avalanche of high-impact pub-
lications reported on novel cases of proteins involved in
LLPS with the numbers still fast increasing, many open
questions remain about the composition of the various con-
densates, their exact biological roles and modes of regu-
lation, and the sequence characteristics of protein regions
that drive LLPS. To a large extent, our limited insight
comes from the lack of a comprehensive, curated database
of experimentally validated LLPS driver proteins/protein
regions. To fill this gap, here we introduce the PhaSePro
database that is a comprehensive, carefully curated resource
of proteins that have been experimentally demonstrated to
drive LLPS.
INFORMATION AVAILABLE IN PhaSePro
PhaSePro (https://phasepro.elte.hu) is a novel database that
provides a wealth of information on LLPS in a structured
way. It is a queryable, public database currently containing
121 entries (as of September 2019) collected through com-
prehensive literature curation. Entries in the database de-
scribe proteins/protein regions that were demonstrated to
drive LLPS together with the supporting literature refer-
ences. Proteins can drive phase separation on their own or as
part of well-defined multicomponent systems, the two sce-
narios being clearly distinguished in PhaSePro. PhaSePro
currently includes 109 eukaryotic, 5 bacterial and 7 viral en-
tries, well illustrating that the formation of liquid conden-
sates through LLPS is a universal mechanism for creating
dynamic subcompartments in the cell that has been demon-
strated across different domains of life, as well as viruses.
We have collected proteins experimentally verified to
drive phase separation in vivo and/or in vitro from the liter-
ature; cases inferred from computational prediction or ho-
mology were not included. The core data represented in
PhaSePro were derived from manual curation, which are
then extended with data automatically retrieved from di-
verse resources (Figure 1).
The bulk of information from manual annotation is en-
coded in a structured way through the use of references to
existing databases, ontologies and custom-built controlled
vocabularies (CVs). The protein sequences investigated in
the experiments addressing LLPS are defined using canoni-
cal UniProt sequences, while for three entries specific iso-
forms needed to be used. The sequence boundaries and
characteristics of the experimentally validated LLPS driver
region(s) are also provided for each entry protein. The exact
sequence regions driving LLPS were confirmed for most of
the entry proteins, while in some cases only the full-length
protein has been subjected to experiments. These scenar-
ios are clearly distinguished in PhaSePro. For the proteins
that are parts of multi-component systems being able to
drive LLPS only together, PhaSePro defines the accessory
proteins needed for LLPS. For all LLPS proteins/systems
PhaSePro provides information on the membraneless or-
ganelle(s) (MO) formed, expressed via GeneOntology cel-
lular component terms.
Position specific information known or assumed to di-
rectly affect LLPS based on the processed literature is spec-
ified using the UniProt sequence as reference. These in-
formation include post-translational modifications, disease
mutations (defined through dbSNP (35) if possible and
connected to OMIM (36)), and alternative splicing events.
In addition, all other isoforms that contain any sequence
changes within the LLPS driver region were also added
from UniProt. Functional and molecular aspects of the or-
ganelle formation derived from the literature are encoded
via purpose-built LLPS-specific CVs (see Supplementary
Tables S1–S4 and next section for details).
The biological function of the formed organelle, the
molecular determinants and the required molecular part-
ners of LLPS are provided in the form of free-text descrip-
tions. To decide whether a given case of LLPS was partner
and/or modification dependent, only experimental param-
eters close to physiological conditions and protein concen-
tration were considered. Experimental procedures used for
the investigation of LLPS are condensed from the relevant
papers by the annotators, and are detailed as free text en-
riched with ontology links (see next section).
Automated annotations also enrich the information pro-
vided by PhaSePro. All post-translational modifications
(PTMs) that have been described for the full protein includ-
ing phosphorylation, methylation, acetylation and ubiq-
uitination were taken from PhosphoSitePlus (37); protein
disorder predictions from the IUPred2A server (38), and
conserved protein region assignations from Pfam (39). Se-
quence variants are imported through ProtVista (40), with
predicted deleterious variants filtered. In addition, all struc-
tures that overlap with the LLPS driving region are im-
ported from PDBe (41).
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Figure 1. Data integrated into PhaSePro. Manual curation (left) is based on the literature. The biological function of the organelle, the partners required
for and other determinants of LLPS are expressed as free text descriptions, while all other annotations are encoded using references to UniProt sequences
or as terms in various ontologies and controlled vocabularies (CVs) (see Supplementary Tables). Automated annotations (top right) are added from the
outputs of various sequence-based prediction methods (IUPred (38) for disorder prediction and Pfam (39) for conserved protein regions), from ProtVista
(40) (for sequence variants omitting predicted variants), from PhosphoSitePlus (37) (for phosphorylation, methylation, acetylation and ubiquitination
sites) and from PDBe (41) (for structures overlapping the LLPS driver region). Entries are cross-linked to various data resources and the data contained
in PhaSePro can be accessed via download or the dedicated API.
For each protein we have a cross-reference to UniProt
entries to include core information, including accessions,
gene/protein names and source species. Other featured
information are linked to the respective database entries
(PDBe, Pfam/PROSITE,OMIM/dbSNP). All information
taken from the literature through manual curation is linked
to corresponding manuscripts via EuropePMC (42).
INTRODUCTION OF LLPS-SPECIFIC CONTROLLED
VOCABULARIES AND EXTENSIONS TO AVAILABLE
ONTOLOGIES
The majority of information in PhaSePro is expressed us-
ing controlled vocabularies (CVs) and ontologies to aid
the findability of the data and the interoperability of the
database, advancing adherence to FAIR principles (43). Us-
ing CVs instead of free text for data representation helps
the interpretation of data, aids computational analyses, and
reduces redundancy of information in databases. Corre-
spondingly, several fields of biology established their re-
spective CVs and ontologies, including biomolecular inter-
actions (44) of post-translational modifications (45). How-
ever, CVs have not been developed for the rapidly expand-
ing field of LLPS, and in parallel with the development of
PhaSePro, we also laid down the foundations of data stan-
dardization by the development of 4 distinct CVs that de-
scribe the following four aspects of LLPS and the mem-
braneless organelles formed.
(i) The functional roles of membraneless organelles
(MOs)/granules in the cell are defined using eight classes
already defined in several dedicated reviews (3–6) (Sup-
plementary Table S1). These include terms such as
‘protective storage/reservoir’ for MOs that store molecules
in an inactive state, or ‘activation/nucleation/signal
amplification/bioreactor’ for MOs that bring together
components of a reaction. (ii) We also introduced a CV
of 19 terms for the different molecular interaction types
that could contribute to LLPS based on (21), including
terms such as ‘multivalent domain-motif interactions’
or ‘coiled-coil formation’ (Supplementary Table S2). (iii)
A dedicated CV with 6 terms was defined to describe
the molecular determinants and mechanisms that are
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pertinent to LLPS, such as the ability of the proteins to
form membrane clusters or if PTMs are required for the
LLPS (Supplementary Table S3). (iv) Finally, the diverse
experimental observations that could support the liquid
state of the condensates, such as temperature-dependence
or the observed dynamic exchange of molecules within the
droplet, were grouped in a separate CV of seven terms that
was partly built based on the review by Mitrea D et al.
(46) (Supplementary Table S4). The terms of these CVs
are explained in more detail on the About/Help page of
PhaSePro.
To ensure the best integration with frequently used on-
tologies, we reviewed the existing classification of mem-
braneless organelles available in Gene Ontology (GO) (47)
(see Supplementary Table S5). Several cellular component
GO terms, falling under the ‘non-membrane bounded or-
ganelle’ parent term already describe membraneless or-
ganelles. However, to make PhaSePro annotations more
precise, we created new terms when it was necessary.
Experimental procedures used for studying liquid–liquid
phase separation were similarly reviewed, connecting them
to terms of the Evidence and Conclusion Ontology (48)
(ECO––see Supplementary Table S6). The use of GO and
ECO are fully in line with the practices of core data re-
sources, such as UniProt, and will enable future integration
and standardization efforts.
IMPLEMENTATION AND SERVER FEATURES
PhaSePro is presented through a DJANGO (version 2.1.1)
based web interface, fueled by a multi-layer SQL database,
which allows a vast amount of parallel queries to be com-
pleted in a fraction of a second. The SQL database con-
tains all the information collected from the literature along-
side with protein information derived from UniProt. Each
record represents a single protein and is linked to a unique
UniProt accession. To maintain the best possible compat-
ibility through the various devices and browsing options
users have, the front-end of PhaSePro is represented solely
as a combination of bootstrap (version 4.3.1) and JQuery
(version 2.1.4).
In addition to access the data through the online inter-
face, data can also be accessed via downloading the data in
JSON, XML or TSV formats, or by the RESTful API serv-
ing standard JSON format (e.g. https://phasepro.elte.hu/
rest/P35637.json). New data currently missing from PhaSe-
Pro can be submitted through a dedicated interface found
on the ‘Annotate’ page.
THE INTERFACE
The online interface of PhaSePro offers convenient ap-
proaches for users to find relevant data. The web-server
opens with aHome page containing general information on
LLPS and specific information of PhaSePro, with links to
two example entry pages, and a search bar, which can be
found on the top of the Browse/Search page as well. The
search bars use a completion based method, offering the
best matches for the queries. The browse function encom-
passes a table containing all entries, where users are able
to filter the database by various options alongside with the
ability to search by keywords or regular expressions. Click-
ing on any row in either the search bar results or inside the
Browse table directs the user to the relevant entry page. Any
set of entries compiled through the use of filters can be fur-
ther customized and downloaded in any of the three avail-
able formats (JSON, XML and TSV).
A comprehensive online documentation about the us-
age and functionalities of PhaSePro are available on the
‘About/Help’ page.
PhaSePro also provides information on candidate pro-
teins that are likely to drive LLPS but their status can-
not be fully ascertained by the available experimental data.
These entries are collected on the ‘Candidates’ page (https:
//phasepro.elte.hu/candidates), which is presented in a simi-
lar fashion as the ‘Browse’ page, with the same functionali-
ties, including the option of downloading them. The ‘Statis-
tics’ page provides various statistics about the database, in-
cluding the fraction of entries with in vivo/in vitro support,
taxonomic distributions of proteins, or the frequencies of
various terms in the four developed CVs.
ENTRY PAGES
Each entry in PhaSePro correspond to a single protein, and
has a dedicated entry page detailing all relevant informa-
tion collected either manually from the literature or in an
automated way from source databases (Figure 2).
The first section of the entry page contains the basic in-
formation on the protein undergoing LLPS and the formed
organelle. The top bar contains information on the release
of the given entry and the annotator(s), and provides the
option of downloading the annotation of the given entry
in JSON, TSV and XML formats. Also, it is indicated here
when the given entry is not a self-sufficient LLPS driver,
but is part of a multi-component system in which the col-
lective behaviour of several proteins are required for LLPS
to occur. This bar is followed by core information on the
given entry protein from UniProt (49) (UniProt accession,
common name, gene name, Ensembl transcript ID, species
name,NCBI taxon ID, and protein name). On the right side,
the PhaSePro core information is provided, namely the spe-
cific membraneless organelle connected to the GO cellular
components system, the specification of the type of exper-
imental evidence (in vitro, in vivo or both), the joined en-
tries (if the given entry is part of a multicomponent LLPS
system) and specific sequence region(s) that drive LLPS, in-
cluding UniProt sequence boundaries and a description of
the domain/compositional/disorder properties of the given
sequence region supported by literature reference.
These core sections are followed by a section for the
graphical representation of sequence- and structure-level
information connected to the protein. For sequence-level
annotations PhaSePro applies the recently released smart
visualization tool of UniProt, ProtVista (40) that enables
mapping of UniProt-annotated features onto the entry pro-
teins, including domain and site information, variations and
disease-associated mutations, and many more. To fit with
the requirements specific for our database, the molecular
features viewer was extended with our annotated LLPS re-
gions. As many regions driving LLPS are intrinsically dis-
ordered and are regulated by posttranslational modifica-
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Figure 2. Entry pages in PhaSePro. Each entry page is structured to display information pertaining to specific aspects of the liquid–liquid phase separation
(LLPS) or the formed membraneless organelles. The figure uses the entry of human Tau protein (https://phasepro.elte.hu/entry/P10636--8).
tions (PTMs), disorder prediction by IUPred (38), domain
predictions by PfamScan (50) and PTMs from Phospho-
SitePlus (37) were also incorporated into the graphical rep-
resentation. We provide an overview of the PDB structures
overlapping with the corresponding LLPS protein regions,
if available, together with a LiteMol structure viewer (51)
for their visualization. The viewer provides an interactive
cartoon-style structural view for the selected overlapping
PDB structure in beige color with the region(s) overlap-
ping the annotated LLPS protein region(s) highlighted in
turquoise in one of the chains belonging to the entry pro-
tein.
The visualization tools are followed by a larger block of
‘Extended LLPS information’ incorporating two separate
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sections. The first section gives a description of the func-
tional relevance and distinctive features of the given LLPS
system using a free-text description distilled by the annota-
tors based on the relevant literature. Together with the de-
scription, a list of related articles is also provided. To rep-
resent the functional class(es) of the formed MO in a more
structured way, it is also defined using the custom built CV
(Supplementary Table S1).
The second part of the extended LLPS section provides
information on the partners and other determinants known
to be required for, or to promote or negatively regulate
LLPS. As several known LLPS events are known to depend
on the presence of RNA, a dedicated block specifies what
type of RNA(s) (if any) are involved. If known, the molecu-
lar interaction types playing a role in driving the givenLLPS
process are also listed using theCVdescribed in Supplemen-
tary Table S2. At the end of this section, categorical classi-
fications of the given LLPS system are provided using the
CV described in Supplementary Table S3.
The ‘Regulation and disease’ section provides detailed
information on the PTMs and alternative splicing events
demonstrated to affect LLPS by experiments. Both types
of data are organized into a strict format, defining the se-
quence change together with other supporting informa-
tion defining the effect the change has on LLPS and cross-
references to supporting literature. Apart from isoforms di-
rectly affecting LLPS, this section also provides alterna-
tive splicing-derived isoforms that have not yet been shown
to have a direct effect on LLPS, but do contain sequence
changes within the annotated LLPS region, and thus may
show an altered LLPS behaviour compared to the canoni-
cal isoform. Disease mutations, whose effects on LLPS have
been experimentally investigated (if any) are also listed us-
ing the sequence variant nomenclature (52), crosslinked to
dbSNP, together with the related diseases crosslinked to
OMIM.
Furthermore, each entry page contains a block of ‘Exper-
imental information’ that contains an extensive textual de-
scription of the LLPS-specific experiments performed that
is enriched with links to associated ECO ontology terms.
Finally, a list of evidence that support the liquid state of the
given condensate backed by literature references is given us-
ing the CV detailed in Supplementary Table S4.
CONCLUSIONS
PhaSePro is a database of proteins driving liquid–liquid
phase separation that aims to provide an up-to-date view on
the variety of biological condensates that rely on LLPS, in-
cluding their major architectural properties, functions and
regulation. It is carefully curated and incorporates experi-
mentally validated LLPS drivers from all kingdoms of life.
We are convinced that PhaSePro will greatly benefit the sci-
entific community by providing (i) a freely accessible, easy-
to-use, organized resource with all relevant data on LLPS
proteins, (ii) the basis for standardization of experimen-
tal approaches and functional characterization, (iii) crucial
data for furthering the elucidation of the sequence deter-
minants and molecular mechanisms enabling liquid–liquid
phase separation and (iv) a high-quality training set for the
development of new methods targeting the computational
identification of novel LLPS proteins.
By storing the most comprehensive list of phase separa-
tion driver proteins published so far, supplied with detailed
annotation on the biological relevance and regulation of
condensates, PhaSePro has a definite potential to become
the central resource in this fast-expanding field. To achieve
this goal we are dedicated to ensure the long-term availabil-
ity of the database.
DATA AVAILABILITY
Our aim is to maintain a regularly updated online resource
with periodic releases at least twice a year, by incorporat-
ing previously published LLPS literature. To successfully
accomplish this goal, we also kindly encourage the scien-
tific community to submit newly identified phase separa-
tion driver proteins to PhaSePro using our detailed down-
loadable annotation guidelines and sample document or the
more simple online submission form (https://phasepro.elte.
hu/annotate). We also encourage authors to contact us if
they have published new information on the already exist-
ing entries. As PhaSePro is located in the EU, data collec-
tion from users and submitters through the server is exe-
cuted via a secure interface using HTTPS, and fully adheres
to the General Data Protection Regulation (GDPR).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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